Honda has introduced the latest version of its popular sporty scooter – the 2025 Dio 125. Now updated to meet the stricter ...

“Skye believes nimacimab shows potential both as a monotherapy and in combination with a GLP-1 targeted drug to address unmet needs in obesity with the potential to change weight loss standards of ...

Honda Dio 125 has been launched in India. The scooter is now OBD-2B compliant, gets a 4.2-inch TFT display which supports ...

The updated Dio 125 features a 4.2-inch TFT display replacing the LCD screen. It supports Honda’s RoadSync app, which ...

Gets bold new graphics, TFT screen, Smart Key, and OBD2B-compliant engine. Targeted at the youth, the updated Dio 125 comes ...

“This new preclinical study highlights that a truly peripherally-restricted CB1 inhibitor—nimacimab—effectively drives weight loss in a DIO model. Nimacimab compared favorably to and ...

Dio is a small company focused on delivering a single product for the Apple ecosystem: a low-cost AirPlay speaker system ...

Honda has launched the 2025 Dio 125 in India, priced at Rs 96,749, ex-showroom. The 2025 Honda Dio 125 is almost Rs 9,000 ...

Honda has updated the Dio 125 for the new model year. The update brings OBD 2B compliance and new features to the scooter., ...

In a murine diet-induced obesity (DIO) model, after 25 days of treatment, results demonstrated: Greater than 30% weight loss when nimacimab was combined with the dual GLP-1/GIP agonist ...

The Honda Dio 125 has been updated to meet the latest OBD2B standards. Prices for this updated model start at Rs 96,749 ...